Q1 2025

Foundation Phase

Core neural mapping algorithms and initial prototype development

  • Complete quantum neural network architecture
  • Biocompatible material testing
  • Safety protocol establishment
  • Initial prototype assembly
Completed
Q2 2025

Testing & Validation

Beta testing program and safety protocol implementation

  • Closed beta testing program
  • FDA safety submissions
  • Performance optimization
  • Clinical trial preparation
In Progress
Q3 2025

Public Launch

Public release and community ecosystem development

  • Commercial product launch
  • Developer SDK release
  • Community platform launch
  • Partnership program initiation
Upcoming
Q4 2025

Global Expansion

Global scaling and advanced feature integration

  • International market expansion
  • Advanced AI capabilities
  • Enterprise solutions
  • Research partnerships
Planned

Beyond 2025

Our long-term vision for neural interface technology

2026

Neural Network Integration

Advanced AI-human collaboration through direct neural connections

2027

Therapeutic Applications

Medical applications for neurological conditions and rehabilitation

2028

Universal Accessibility

Making neural interfaces accessible to everyone, regardless of ability

Development Progress

85%
Hardware Development
92%
Software Integration
78%
Safety Testing
65%
Regulatory Approval